Video
Some pharmaceutical manufacturers choose a limited distribution model for their specialty product so that they can ensure all standards of care and reporting associated with that therapy are upheld, noted Duane Barnes, senior vice president, consumer delivery, Prime Therapeutics, at the 2013 Armada Specialty Pharmacy Summit.
Some pharmaceutical manufacturers choose a limited distribution model for their specialty product so that they can ensure all standards of care and reporting associated with that therapy are upheld, noted Duane Barnes, senior vice president, consumer delivery, Prime Therapeutics, at the 2013 Armada Specialty Pharmacy Summit.
For more videos from the Armada Specialty Pharmacy Summit, visit our Multimedia page.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa